HCC patients with high serum AFP (>400 ng/mL) had a poor outcome and showed significant upregulation of signaling pathways—not only VEGF but also IGF1R, NOTCH, and mTOR [22]. The gene discussed is AFP; the disease is hepatocellular carcinoma.